US-Klagen: Bayer und Kläger wollen Anhörung zum Glyphosat-Sammelvergleich verschieben
Im Rechtsstreit um den Unkrautvernichter wollen sich beide Seiten später als zunächst geplant vor Gericht treffen. Dadurch gibt es mehr Zeit zur Prüfung wichtiger Anträge.
In a legal dispute concerning the weed killer glyphosate, both Bayer AG and the plaintiffs' lawyers intend to postpone the hearing for final approval of their collective settlement. The scheduled date for the hearing, set for September 10th or a later time, was announced by Bayer on Wednesday. The request for postponement was submitted to the relevant court in Missouri, United States, according to Bayer.
This delay of approximately three weeks aims to provide the involved parties and the program administrator with additional time to process requests for withdrawing from the agreement, known as "opt-outs," which were submitted following a ruling by the United States Supreme Court.
The U.S. Supreme Court's decision at the end of June determined that plaintiffs could not sue Bayer for the absence of a cancer warning on the label of the weed killer Roundup. The U.S. Environmental Protection Agency (EPA) classified glyphosate as not carcinogenic and approved labels without such a warning. Despite this, Bayer was repeatedly found liable by jury trials in various U.S. states, resulting in substantial compensation awards.
The wave of lawsuits involving the company following its acquisition of Monsanto's glyphosate developer has been a burden on Bayer for years, costing the company billions of dollars.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
